PURPOSE: Lymph node involvement is the most important prognostic factor in breast
cancer. It is a multifactorial event determined by patient and tumour characteristics. The …

Materials and Methods All patients enrolled in the Clinical Breast Care Project whose
tumour site—UOQ, upper inner quadrant (UIQ), central, LIQ, lower outer quadrant (LOQ) …

Background The malignant probability of Breast Imaging Reporting and Data System (BI-
RADS) 4 breast lesions is 3–94%, which is a very large span, and thus leads to a high rate …

The pathological status of axillary lymph nodes (ALN) plays a critical role in the staging and
treatment of patients with breast cancer. Therefore, differential diagnosis of metastatic ALN is …

Background Tumor characteristics was sought to be related to axillary lymph node
metastasis (ALNM), the paramount prognostic factor in patients with invasive breast cancer …

We examined the association between the hormone receptor (HR) and human epidermal
growth factor receptor 2 (HER2) status of women with primary breast cancer and the risk of …

Objectives: Lymphovascular invasion (LVI) has been associated with a poor outcome in
patients with breast cancer, but it is not included in international TNM staging system and …

Objective: Sentinel lymph node biopsy (SLNB) is the standard of care for axillary staging in
clinically node negative breast cancer. If predictive factors for sentinel lymph node (SLN) …

This study was to investigate the correlation between contrast‐enhanced ultrasonography
(CEUS) characteristics with prognostic factors in breast cancers with different sizes. A …

Predicting the risk of sentinel lymph node (SLN) metastasis is important for clinical decision-
making in the setting of early breast cancer (EBC). This study is aimed to identify tumor and …